Phase: Phase IIIType: TreatmentAge: 60 and overTrial IDs: AG-221-AML-004, NCI-2015-01945, NCT02577406Phase: Phase II, Phase IType: Biomarker/Laboratory analysis, TreatmentAge: 18 and overTrial IDs: AG-221-C-001, NCI-2013-01928, NCT01915498Phase: Phase II, Phase IType: Biomarker/Laboratory analysis, TreatmentAge: 18 and overTrial IDs: BS FF1050101US01, NCI-2014-01590, NCT02193958
